Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.
about
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisIntracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicineIn vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasitesNovel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophagesProtein network prediction and topological analysis in Leishmania major as a tool for drug target selection.Body weight as a determinant of clinical evolution in hamsters (Mesocricetus auratus) infected with Leishmania (Viannia) panamensisThe immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils.Development and validation of four Leishmania species constitutively expressing GFP protein. A model for drug discovery and disease pathogenesis studies.Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.Leishmaniasis Panamensis Masquerading as Myiasis and Sporotrichosis: A Clinical PitfallAn alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.Silver nanoparticles and electroporation: Their combinational effect on Leishmania major.Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida.New application for expanded porphyrins: sapphyrin and heterosapphyrins as inhibitors of Leishmania parasites.Flow cytometric screening for anti-leishmanials in a human macrophage cell line.Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.Antileishmanial Effect of 5,3'-Hydroxy-7,4'-dimethoxyflavanone of Picramnia gracilis Tul. (Picramniaceae) Fruit: In Vitro and In Vivo Studies.A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery.EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein.Downregulation of Calcineurin Gene Is Associated with Glucantime(®) Resiatance in Leishmania infantum.DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening.Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
P2860
Q26786195-40A72613-AB95-4FDA-BE15-22A0571A046DQ28478461-2E76D2E0-8F55-4923-B108-7617BDA4D845Q28482212-D98FB6FC-8A3E-4071-83D0-3B598037D1D0Q28830321-5FAD5A81-9A47-4575-BC11-0FA1D955AFF1Q33704536-15D7A7DE-37FE-4F62-BF49-147AF03EAA4BQ33926482-91838050-673E-4F76-AC34-C92E2A5F5055Q34219774-FC618662-8995-4D8E-AF46-7C2A0326697AQ34251158-1D8B789C-C421-4AC7-8E6F-EE16DBC1DAB7Q35047048-BD24540A-2333-4AB0-8058-1C769D763D92Q35960805-0139E3F9-6B20-4FD7-88CC-0091D6BEF4CEQ36054770-582A19BF-19F6-48C3-AB3F-533E460E55FBQ37069597-525670D2-6CCD-454B-ACB1-6E2B6D4D9068Q38803524-68DB19BF-D1DB-4978-AFCC-AAAAAE419E2EQ38981155-0B30884A-7490-4F49-A036-240A7E68BB70Q39445912-3165FAC6-49E4-493F-AD47-5477C117EF06Q39694329-2F393EF5-1A30-490F-8C51-18C4782FF6E5Q40084369-0492B407-8498-483D-9B4E-6EBA317573C2Q40385380-99403B22-887B-481B-B14A-8E30B1DF55B4Q40637964-551FDEE2-664D-4188-93FC-6CAF0FA423B1Q40676578-9BBD65AA-2118-4B90-97A6-1B111D21A30CQ40864828-787A451E-B973-4881-874D-66818CD8717CQ41125410-7DB060CC-C344-4B4A-8A6C-2B3A2D45B8C8Q41863445-B6D2ED55-9B57-4EFD-8AC5-640EFC83D4CFQ50229835-5EEC8EAE-5519-4C08-B4E3-F4B3D19ABDDAQ55210168-72CFB808-A329-43EB-9A10-7490B61F29AD
P2860
Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Leishmania (Viannia) panamensi ...... ening of antileishmanial drug.
@en
type
label
Leishmania (Viannia) panamensi ...... ening of antileishmanial drug.
@en
prefLabel
Leishmania (Viannia) panamensi ...... ening of antileishmanial drug.
@en
P2093
P2860
P1476
Leishmania (Viannia) panamensi ...... eening of antileishmanial drug
@en
P2093
Bala K Kolli
Carlos Muskus
Diana Lorena Muñoz
Sara M Robledo
Sujoy Dutta
P2860
P304
P356
10.1016/J.EXPPARA.2009.02.012
P577
2009-03-20T00:00:00Z